The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Clinical practice guideline: Acute otitis externa
Abstract
OBJECTIVE: This guideline provides evidence‐based recommendations to manage diffuse acute otitis externa (AOE), defined as generalized inflammation of the external ear canal, which may also involve the pinna or tympanic membrane. The primary purpose is to promote appropriate use of oral and topical antimicrobials and to highlight the need for adequate pain relief. STUDY DESIGN: In creating this guideline, the American Academy of Otolaryngology‐Head and Neck Surgery Foundation (AAO‐HNSF) selected a development group representing the fields of otolaryngology‐head and neck surgery, pediatrics, family medicine, infectious disease, internal medicine, emergency medicine, and medical informatics. The guideline was created with the use of an explicit, a priori, evidence‐based protocol. RESULTS: The group made a strong recommendation that management of AOE should include an assessment of pain, and the clinician should recommend analgesic treatment based on the severity of pain. The group made recommendations that clinicians should: 1) distinguish diffuse AOE from other causes of otalgia, otorrhea, and inflammation of the ear canal; 2) assess the patient with diffuse AOE for factors that modify management (nonintact tympanic membrane, tympanostomy tube, diabetes, immunocompromised state, prior radiotherapy); and 3) use topical preparations for initial therapy of diffuse, uncomplicated AOE; systemic antimicrobial therapy should not be used unless there is extension outside of the ear canal or the presence of specific host factors that would indicate a need for systemic therapy. The group made additional recommendations that: 4) the choice of topical antimicrobial therapy of diffuse AOE should be based on efficacy, low incidence of adverse events, likelihood of adherence to therapy, and cost; 5) clinicians should inform patients how to administer topical drops, and when the ear canal is obstructed, delivery of topical preparations should be enhanced by aural toilet, placing a wick, or both; 6) when the patient has a tympanostomy tube or known perforation of the tympanic membrane, the clinician should prescribe a nonototoxic topical preparation; and 7) if the patient fails to respond to the initial therapeutic option within 48 to 72 hours, the clinician should reassess the patient to confirm the diagnosis of diffuse AOE and to exclude other causes of illness. And finally, the panel compiled a list of research needs based on limitations of the evidence reviewed. CONCLUSION: This clinical practice guideline is not intended as a sole source of guidance in evaluating patients with AOE. Rather, it is designed to assist clinicians by providing an evidence‐based framework for decision‐making strategies. It is not intended to replace clinical judgment or establish a protocol for all individuals with this condition and may not provide the only appropriate approach to the diagnosis and management of this problem. SIGNIFICANCE: This is the first, explicit, evidence‐based clinical practice guideline on acute otitis externa, and the first clinical practice guideline produced independently by the AAO‐HNSF. © 2006 American Academy of Otolaryngology‐Head and Neck Surgery Foundation, Inc. All rights reserved.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Systematic Reviews: Identifying relevant studies for systematic reviews
Dickersin, K., Scherer, R., & Lefebvre, C. (1994) · BMJ · doi:10.1136/bmj.309.6964.1286 · Cited by 2,256
Cummings Otolaryngology: Head and Neck Surgery
Flint, E. B. P. W., Haughey, B. H., Lund, V. J., Niparko, J. K., Robbins, K. T., Thomas, J. R., & Lesperance, M. M. (2004) · Cited by 1,439
Ann Otol Rhinol Laryngol [Suppl].
Cw, C. (1978) · PubMed · Cited by 1,313
Bieri, D., Reeve, R. A., Champion, D. G., Addicoat, L., & Ziegler, J. B. (1990) · Pain · doi:10.1016/0304-3959(90)90018-9 · Cited by 1,119
Ward, A. (2002) · Acupuncture in Medicine · doi:10.1136/aim.20.4.207-a · Cited by 1,075
Diagnosis and Management of Acute Otitis Media
Media, S. O. M. O. A. O. (2004) · Pediatrics · doi:10.1542/peds.113.5.1451 · Cited by 902
The Assessment and Management of Acute Pain in Infants, Children, and Adolescents
Committee on Psychosocial Aspects of Child and Family Health, & Task Force on Pain in Infants, C. (2001) · Pediatrics · doi:10.1542/peds.108.3.793 · Cited by 829
Loeser, J. D. (2001) · Cited by 792
The Diagnosis and Management of Acute Otitis Media
(2021) · Pediatric Clinical Practice Guidelines & Policies, 21st Ed · doi:10.1542/9781610025034-part01-the_diagnosis · Cited by 692
Research works printed but not linked: 89
- 10.1177/00034894991080S201 · doi:10.1177/00034894991080s201
- 10.1017/S0022215100129469 · doi:10.1017/s0022215100129469
- 10.1097/00005537-200207000-00005 · doi:10.1097/00005537-200207000-00005
- 10.1016/S0163-4453(05)80004-0 · doi:10.1016/s0163-4453(05)80004-0
- Clark WB, 1997, Microbiology of otitis externa., Otolarngol Head Neck Surg, 116, 23
- 10.1001/archotol.1997.01900110047007 · doi:10.1001/archotol.1997.01900110047007
- 10.1097/00019048-199911000-00009 · doi:10.1097/00019048-199911000-00009
- Arshad M, 2004, Sensitivity and spectrum of bacterial isolates in infectious otitis externa., J Coll Physicians Surg Pak, 14, 146
- Hajioff D, 2004, Otitis externa., Clin Evid, 12, 755
- 10.1056/NEJM196302072680604 · doi:10.1056/nejm196302072680604
- 10.1046/j.1365-2273.2003.00713.x · doi:10.1046/j.1365-2273.2003.00713.x
- 10.5694/j.1326-5377.1992.tb139790.x · doi:10.5694/j.1326-5377.1992.tb139790.x
- Blake P, 1998, When not to syringe an ear., N Z Med J, 111, 422
- Berry RG, 1993, Otitis externa and facial cellulitis from Oriental ear cleaners., West J Med, 158, 536
- 10.1288/00005537-198407000-00020 · doi:10.1288/00005537-198407000-00020
- 10.1017/S0022215100124739 · doi:10.1017/s0022215100124739
- 10.1080/00039896.1982.10667583 · doi:10.1080/00039896.1982.10667583
- Hansen US, 1997, Otitis externa among users of private swimming pools., Ugeskr Laeger, 159, 4383
- Moore JE, 2002, Incidence of Pseudomonas aeruginosa in recreational and hydrotherapy pools., Commun Dis Public Health, 5, 23
- 10.2166/wst.2004.0020 · doi:10.2166/wst.2004.0020
- 10.1159/000276728 · doi:10.1159/000276728
- 10.1001/archotol.1996.01890200023004 · doi:10.1001/archotol.1996.01890200023004
- 10.1016/S0030-6665(20)30314-5 · doi:10.1016/s0030-6665(20)30314-5
- 10.1016/S0149-2918(99)80027-7 · doi:10.1016/s0149-2918(99)80027-7
- Kaushik V, 2004, Interventions for otitis externa (protocol)., Cochrane Database Syst Rev, 2, CD004740
- Lucente FE, 1995, External ear.
- 10.1111/j.1365-4362.1981.tb00817.x · doi:10.1111/j.1365-4362.1981.tb00817.x
- 10.1001/archderm.1973.01620250025006 · doi:10.1001/archderm.1973.01620250025006
- Larsson‐Styme B, 1985, Ear piercing: a cause of nickel allergy in schoolgirls?, Contact Dermatitis, 13, 268
- 10.1097/00003446-199204000-00009 · doi:10.1097/00003446-199204000-00009
- 10.3109/03005368709077787 · doi:10.3109/03005368709077787
- Schapowal A, 2001, Contact dermatitis to antibiotic ear drops is due to neomycin but not to ciprofloxacin [abstract]., Allergy, 56, 148
- 10.1258/00222150260293691 · doi:10.1258/00222150260293691
- 10.1258/0022215041615100 · doi:10.1258/0022215041615100
- 10.1177/014556130007900815 · doi:10.1177/014556130007900815
- 10.1016/S0305-7372(03)00066-5 · doi:10.1016/s0305-7372(03)00066-5
- 2001, Pain: current understanding of assessment, management and treatments.
- Valencia CG, 1987, Potassium diclofenac vs placebo in acute otitis externa: a double‐blind, comparative study [Spanish]., Invest Med Int, 14, 56
- 10.1017/S0022215100114252 · doi:10.1017/s0022215100114252
- 10.1136/bmj.327.7425.1201 · doi:10.1136/bmj.327.7425.1201
- 10.1017/S0022215100102178 · doi:10.1017/s0022215100102178
- Psifidis A, 2005, The efficacy and safety of local ciprofloxacin in patients with external otitis: a randomized comparative study., Mediterranean J Otol Audiol, 1
- 10.1177/000348949110000806 · doi:10.1177/000348949110000806
- Cannon SJ, 1967, Treatment of otitis externa with a topical steroid‐antibiotic combination: a controlled clinical trial., Eye Ear Nose Throat Monthly, 46, 1296
- Cannon S, 1970, External otitis: controlled therapeutic trial., Eye Ear Nose Throat Monthly, 49, 186
- Freedman R, 1978, Versus placebo in treatment of acute otitis externa., Ear Nose Throat J, 57, 198
- Pedersen CB, 1971, Otitis externa treated with locacortenvioform ear drops [Danish]., Ugeskrift for Laeger, 133, 389
- 10.5694/j.1326-5377.1993.tb121918.x · doi:10.5694/j.1326-5377.1993.tb121918.x
- Kime CE, 1978, Effective treatment of acute diffuse otitis externa: II. a controlled comparison of hydrocortisone‐acetic acid, nonaqueous and hydrocortisone‐neomycin‐colistin otic solutions., Curr Ther Res Clin Exp, 23, ss15
- Ordonez GE, 1978, Effective treatment of acute diffuse otitis externa: I. a controlled comparison of hydrocortisone‐acetic acid, non‐aqueous and hydrocortisone‐neomycin‐polymyxin B otic solutions., Curr Ther Res Clin Exp, 23, ss3
- 10.1111/j.1365-2273.1990.tb00425.x · doi:10.1111/j.1365-2273.1990.tb00425.x
- Lambert IJ, 1981, A comparison of the treatment of otitis externa with Otosporin and aluminium acetate: a report from a services practice in Cyprus., J Royal Col Gen Pract, 31, 291
- 10.1097/00007611-197705000-00011 · doi:10.1097/00007611-197705000-00011
- 10.1258/002221504772784513 · DOI
- 10.1097/00005537-200405000-00011 · doi:10.1097/00005537-200405000-00011
- 10.1007/BF00183171 · doi:10.1007/bf00183171
- 10.1258/0022215053945705 · doi:10.1258/0022215053945705
- Bak JP, 1983, Treatment of otitis externa with miconazole nitrate: a comparative study involving 85 cases., S Afr Med J, 63, 562
- 10.1046/j.1365-2273.2001.00455.x · doi:10.1046/j.1365-2273.2001.00455.x
- 10.1097/00007611-200405000-00010 · doi:10.1097/00007611-200405000-00010
- 10.1080/00913847.1991.11702213 · doi:10.1080/00913847.1991.11702213
- 10.1080/00913847.1986.11709152 · doi:10.1080/00913847.1986.11709152
- 10.1185/03007999309111548 · doi:10.1185/03007999309111548
- 10.1053/ajot.2002.123461 · doi:10.1053/ajot.2002.123461
- 10.1185/030079902125004312 · doi:10.1185/030079902125004312
- Sabater F, 1996, Prospective double‐blind randomized study of the efficacy and tolerance of topical ciprofloxacin vs topical gentamicin in the treatment of simple chronic otitis media and diffuse external otitis [Spanish]., Acta Otorrinolaryngol Esp, 47, 217
- 10.1016/j.ijporl.2005.01.022 · doi:10.1016/j.ijporl.2005.01.022
- 10.3109/00016488509126565 · doi:10.3109/00016488509126565
- 10.1111/j.1365-2273.1995.tb00052.x · doi:10.1111/j.1365-2273.1995.tb00052.x
- 10.1017/S0022215100123801 · doi:10.1017/s0022215100123801
- 10.1016/S0149-2918(04)90176-2 · doi:10.1016/s0149-2918(04)90176-2
- 10.1258/0022215053561495 · doi:10.1258/0022215053561495
- 10.1177/014556139607500906 · doi:10.1177/014556139607500906
- 10.1258/0022215001903834 · doi:10.1258/0022215001903834
- 10.1111/j.1365-2273.1994.tb01198.x · doi:10.1111/j.1365-2273.1994.tb01198.x
- 10.1016/0002-9343(88)90592-X · doi:10.1016/0002-9343(88)90592-x
- 10.1017/S0022215100113696 · doi:10.1017/s0022215100113696
- 10.1056/NEJM199109263251320 · doi:10.1056/nejm199109263251320
- 10.1258/0022215021911130 · doi:10.1258/0022215021911130
- 10.1097/00005537-200112000-00004 · doi:10.1097/00005537-200112000-00004
- 10.1080/000164801300043208 · doi:10.1080/000164801300043208
- 10.1016/j.otohns.2003.12.008 · doi:10.1016/j.otohns.2003.12.008
- Rakover Y, 1997, Safety of topical ear drops containing ototoxic antibiotics., J Otolaryngol, 26, 194
- Abello P, 1998, Topical ototoxicity: review over a 6‐year period [Spanish]., Acta Otorrinolaringol Esp, 49, 353
- Linder TE, 1995, Ototoxicity of ear drops: a clinical perspective., Am J Otol, 16, 653
- 2003, Cortisporin Otic Suspension Sterile package insert.
- 10.1097/00005537-200309000-00016 · doi:10.1097/00005537-200309000-00016
- Devos SA, 2000, The relevance of positive patch test reactions in chronic otitis externa., Contact Dermatitis, 42, 354
- 10.1177/01455613040839s408 · doi:10.1177/01455613040839s408
Cited by
Clinical Practice Guideline: Tympanostomy Tubes in Children
Rosenfeld, R. M., Schwartz, S. R., Pynnonen, M. A., Tunkel, D. E., Hussey, H. M., Fichera, J. S., Grimes, A. M., Hackell, J. M., Harrison, M. F., Haskell, H., et al. (2013) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599813487302 · Cited by 442
Self-citationShariati, A., Arshadi, M., Khosrojerdi, M. A., Abedinzadeh, M., Ganjalishahi, M., Maleki, A., Heidary, M., & Khoshnood, S. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1025633 · Cited by 337
Pane, G., Cacciola, G., Giacco, E., Mariottini, G., & Coppo, E. (2015) · Marine Drugs · doi:10.3390/md13106440 · Cited by 56
Metadata
- Authors
- Rosenfeld, R. M., Brown, L., Cannon, C. R., Dolor, R. J., Ganiats, T. G., Hannley, M., Kokemueller, P., Marcy, S. M., Roland, P. S., Shiffman, R. N., Stinnett, S. S., & Witsell, D. L.
- Venue
- Otolaryngology–Head and Neck Surgery
- Publisher
- Wiley
- Published
- 2006-04
- Volume
- 134
- Issue
- S4
- Pages
- S1-S24
- ISSN
- 0161-6439 (ISSN-L)
- 0194-5998
- 1097-6817
- OpenAlex
- W2163398872
- Cited by
- 270
- References
- 59
- FWCI
- 7.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical practice guideline: Acute otitis externa. https://app.cochat.ai/papers/10.1016/j.otohns.2006.02.014
- The paper
- Rosenfeld, R. M., Brown, L., Cannon, C. R., Dolor, R. J., Ganiats, T. G., Hannley, M., Kokemueller, P., Marcy, S. M., Roland, P. S., Shiffman, R. N., Stinnett, S. S., & Witsell, D. L. (2006). Clinical practice guideline: Acute otitis externa. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1016/j.otohns.2006.02.014
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.